Summit Therapeutics shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $1.0M | 60k | 17.49 |
| 2024-12-31 | $229k | 13k | 17.85 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management